Cosmo Pharmaceuticals NV revenue for the last year amounted to 106.76 M USD, the most of which — 57.65 M USD — came from its highest performing source at the moment, Own Products, the year earlier bringing 46.73 M USD. The greatest contribution to the revenue figure was made by Italy — last year it brought Cosmo Pharmaceuticals NV 110.81 M USD, and the year before that — 77.08 M USD.